{"address1": "Kaiser-Wilhelm-Allee 1", "city": "Leverkusen", "zip": "51368", "country": "Germany", "phone": "49 214 30 1", "website": "https://www.bayer.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.", "fullTimeEmployees": 96931, "companyOfficers": [{"maxAge": 1, "name": "Mr. William N. Anderson", "age": 57, "title": "Chairman of the Management Board & CEO", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 8429104, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wolfgang U. Nickl", "age": 54, "title": "CFO & Member of Management Board", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1982000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Heiko W. J. Schipper", "age": 54, "title": "Member of Management Board & President of the Consumer Health Division", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1945000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stefan  Oelrich", "age": 55, "title": "Head of the Pharmaceuticals Division & Member of the Board of Management", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1946000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rodrigo  Santos", "age": 50, "title": "Member of Management Board & President of the Crop Science Division", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 2165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heike  Prinz", "age": 59, "title": "Chief Talent Officer, Labor Director & Member of Management Board", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 1329000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jost  Reinhard", "age": 51, "title": "Head of Investor Relations", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Preuss", "title": "Head of Communications, Government Relations and Corporate Brand", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernd-Peter  Bier", "age": 56, "title": "Head of Group Finance", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  LaCaze", "title": "Executive VP & Head of the Oncology Strategic Business Unit", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 2, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 6, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 26.215, "open": 26.36, "dayLow": 26.32, "dayHigh": 26.685, "regularMarketPreviousClose": 26.215, "regularMarketOpen": 26.36, "regularMarketDayLow": 26.32, "regularMarketDayHigh": 26.685, "dividendRate": 0.11, "dividendYield": 0.0042, "exDividendDate": 1714348800, "payoutRatio": 1.6327001, "fiveYearAvgDividendYield": 4.62, "beta": 0.974, "forwardPE": 4.6701937, "volume": 3619141, "regularMarketVolume": 3619141, "averageVolume": 4603302, "averageVolume10days": 5257354, "averageDailyVolume10Day": 5257354, "bid": 26.5, "ask": 26.51, "bidSize": 28400, "askSize": 2100, "marketCap": 26014586880, "fiftyTwoWeekLow": 24.96, "fiftyTwoWeekHigh": 61.91, "priceToSalesTrailing12Months": 0.54610044, "fiftyDayAverage": 29.1294, "twoHundredDayAverage": 40.289173, "trailingAnnualDividendRate": 0.11, "trailingAnnualDividendYield": 0.004196071, "currency": "EUR", "enterpriseValue": 60324245504, "profitMargins": -0.061739996, "floatShares": 982316015, "sharesOutstanding": 982424000, "heldPercentInsiders": 0.00026, "heldPercentInstitutions": 0.49051997, "impliedSharesOutstanding": 982424000, "bookValue": 33.516, "priceToBook": 0.7900704, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 1.188, "netIncomeToCommon": -2940999936, "trailingEps": -2.99, "forwardEps": 5.67, "pegRatio": -1.49, "enterpriseToRevenue": 1.266, "enterpriseToEbitda": 5.324, "52WeekChange": -0.5313729, "SandP52WeekChange": 0.32311738, "lastDividendValue": 0.11, "lastDividendDate": 1714348800, "exchange": "GER", "quoteType": "EQUITY", "symbol": "BAYN.DE", "underlyingSymbol": "BAYN.DE", "shortName": "BAYER AG NA O.N.", "longName": "Bayer Aktiengesellschaft", "firstTradeDateEpochUtc": 850723200, "timeZoneFullName": "Europe/Berlin", "timeZoneShortName": "CET", "uuid": "9932cc3b-14ad-302f-8869-bd133abe65ab", "messageBoardId": "finmb_103375", "gmtOffSetMilliseconds": 3600000, "currentPrice": 26.48, "targetHighPrice": 61.0, "targetLowPrice": 25.0, "targetMeanPrice": 35.6, "targetMedianPrice": 33.0, "recommendationMean": 2.9, "recommendationKey": "hold", "numberOfAnalystOpinions": 22, "totalCash": 10586999808, "totalCashPerShare": 10.776, "ebitda": 11331000320, "totalDebt": 45006000128, "quickRatio": 0.784, "currentRatio": 1.275, "totalRevenue": 47637000192, "debtToEquity": 136.06, "revenuePerShare": 48.489, "returnOnAssets": 0.040430002, "returnOnEquity": -0.08172, "freeCashflow": 1518625024, "operatingCashflow": 5117000192, "earningsGrowth": 1.195, "revenueGrowth": -0.012, "grossMargins": 0.58549, "ebitdaMargins": 0.23786, "operatingMargins": 0.79042, "financialCurrency": "EUR", "trailingPegRatio": null}